Cargando…
Bromodomain factor 5 is an essential regulator of transcription in Leishmania
Leishmania are unicellular parasites that cause human and animal diseases. Like other kinetoplastids, they possess large transcriptional start regions (TSRs) which are defined by histone variants and histone lysine acetylation. Cellular interpretation of these chromatin marks is not well understood....
Autores principales: | Jones, Nathaniel G., Geoghegan, Vincent, Moore, Gareth, Carnielli, Juliana B. T., Newling, Katherine, Calderón, Félix, Gabarró, Raquel, Martín, Julio, Prinjha, Rab K., Rioja, Inmaculada, Wilkinson, Anthony J., Mottram, Jeremy C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279504/ https://www.ncbi.nlm.nih.gov/pubmed/35831302 http://dx.doi.org/10.1038/s41467-022-31742-1 |
Ejemplares similares
-
Bromodomain
Factor 5 as a Target for Antileishmanial
Drug Discovery
por: Russell, Catherine N., et al.
Publicado: (2023) -
Essential roles for deubiquitination in Leishmania life cycle progression
por: Damianou, Andreas, et al.
Publicado: (2020) -
CLK1/CLK2-driven signalling at the Leishmania kinetochore is captured by spatially referenced proximity phosphoproteomics
por: Geoghegan, Vincent, et al.
Publicado: (2022) -
Bromodomain Proteins Contribute to Maintenance of Bloodstream Form Stage Identity in the African Trypanosome
por: Schulz, Danae, et al.
Publicado: (2015) -
N-terminal BET bromodomain inhibitors disrupt a BRD4-p65 interaction and reduce inducible nitric oxide synthase transcription in pancreatic β-cells
por: Nord, Joshua A., et al.
Publicado: (2022)